MX2010004025A - Antagonistas de glucosaminoglicano basados en sdf-1 y metodos de uso de los mismos. - Google Patents
Antagonistas de glucosaminoglicano basados en sdf-1 y metodos de uso de los mismos.Info
- Publication number
- MX2010004025A MX2010004025A MX2010004025A MX2010004025A MX2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- sdf
- antagonists
- same
- glycosaminoglycan
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 1
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 abstract 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07450189A EP2053060A1 (en) | 2007-10-24 | 2007-10-24 | SDF-1-based glyocosaminoglycan antagonists and methods of using same |
| PCT/EP2008/008960 WO2009053064A1 (en) | 2007-10-24 | 2008-10-23 | Sdf-1-based glycosaminoglycan antagonists and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010004025A true MX2010004025A (es) | 2010-04-30 |
Family
ID=39133777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010004025A MX2010004025A (es) | 2007-10-24 | 2008-10-23 | Antagonistas de glucosaminoglicano basados en sdf-1 y metodos de uso de los mismos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100298203A1 (enExample) |
| EP (2) | EP2053060A1 (enExample) |
| JP (1) | JP2011501675A (enExample) |
| KR (1) | KR20100085041A (enExample) |
| CN (1) | CN101835800A (enExample) |
| AU (1) | AU2008315614A1 (enExample) |
| BR (1) | BRPI0818009A2 (enExample) |
| CA (1) | CA2702502A1 (enExample) |
| EA (1) | EA201000688A1 (enExample) |
| IL (1) | IL205300A0 (enExample) |
| MX (1) | MX2010004025A (enExample) |
| NZ (1) | NZ584278A (enExample) |
| WO (1) | WO2009053064A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120080196A (ko) * | 2009-09-11 | 2012-07-16 | 프로타핀 바이오테크놀로기 아게 | Ｃｘｃｌ８-매개의 폐 염증을 치료하는 조성물 |
| CN102094043B (zh) * | 2010-11-23 | 2012-11-07 | 山东农业大学 | 猪趋化因子cxcl12基因及其应用 |
| WO2012123585A1 (en) | 2011-03-16 | 2012-09-20 | Protaffin Biotechnologie Ag | Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same |
| EP2729487A2 (en) | 2011-07-08 | 2014-05-14 | Protaffin Biotechnologie AG | Novel sdf-1-based glycosaminoglycan antagonist and methods of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364894A (en) * | 1993-03-31 | 1994-11-15 | Tremco, Inc. | Emulsification of asphalt and modified asphalt with primary emulsifier polymers comprised of acrylic acid type monomers |
| EP0915969A4 (en) * | 1996-04-02 | 2002-04-17 | Progenics Pharm Inc | SUPPRESSION OF CD4 + CELL INFECTION BY HIV |
| DE60103052T2 (de) * | 2000-05-09 | 2005-03-03 | The University Of British Columbia, Vancouver | Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten |
| WO2004094465A2 (en) * | 2003-04-23 | 2004-11-04 | The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign | Synthetic molecules that mimic chemokines |
| AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
| US7662221B2 (en) * | 2006-06-23 | 2010-02-16 | Johns Manville | Spray applied building wrap coating material, spray applied building wrap, and building construction assembly |
| AT504685B1 (de) * | 2006-12-20 | 2009-01-15 | Protaffin Biotechnologie Ag | Fusionsproteine |
-
2007
- 2007-10-24 EP EP07450189A patent/EP2053060A1/en not_active Withdrawn
-
2008
- 2008-10-23 CN CN200880113405A patent/CN101835800A/zh active Pending
- 2008-10-23 EA EA201000688A patent/EA201000688A1/ru unknown
- 2008-10-23 US US12/738,976 patent/US20100298203A1/en not_active Abandoned
- 2008-10-23 AU AU2008315614A patent/AU2008315614A1/en not_active Abandoned
- 2008-10-23 JP JP2010530341A patent/JP2011501675A/ja active Pending
- 2008-10-23 EP EP08842736A patent/EP2203473A1/en not_active Withdrawn
- 2008-10-23 WO PCT/EP2008/008960 patent/WO2009053064A1/en not_active Ceased
- 2008-10-23 MX MX2010004025A patent/MX2010004025A/es not_active Application Discontinuation
- 2008-10-23 CA CA2702502A patent/CA2702502A1/en not_active Abandoned
- 2008-10-23 BR BRPI0818009 patent/BRPI0818009A2/pt not_active IP Right Cessation
- 2008-10-23 KR KR1020107008264A patent/KR20100085041A/ko not_active Ceased
- 2008-10-23 NZ NZ584278A patent/NZ584278A/en not_active IP Right Cessation
-
2010
- 2010-04-22 IL IL205300A patent/IL205300A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201000688A1 (ru) | 2010-10-29 |
| KR20100085041A (ko) | 2010-07-28 |
| IL205300A0 (en) | 2010-12-30 |
| AU2008315614A1 (en) | 2009-04-30 |
| CN101835800A (zh) | 2010-09-15 |
| WO2009053064A1 (en) | 2009-04-30 |
| JP2011501675A (ja) | 2011-01-13 |
| NZ584278A (en) | 2012-06-29 |
| WO2009053064A8 (en) | 2009-07-16 |
| EP2053060A1 (en) | 2009-04-29 |
| US20100298203A1 (en) | 2010-11-25 |
| CA2702502A1 (en) | 2009-04-30 |
| EP2203473A1 (en) | 2010-07-07 |
| BRPI0818009A2 (pt) | 2015-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200716646A (en) | (S)-N-methylnaltrexone | |
| UA90048C2 (ru) | Кондиционированная композиция и способ ее получения | |
| AU2010233994A8 (en) | Bispecific anti-ErbB-3/anti-c-Met antibodies | |
| MX339201B (es) | Compuestos de sulfonamida y métodos para elaborarlos y usarlos. | |
| MY165582A (en) | Azetidine and cyclobutane derivatives as jak inhibitors | |
| MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
| JO2576B1 (en) | Antibodies | |
| MX2011010908A (es) | Anticuerpos anti-tnf-alfa y sus usos. | |
| AU2012253759A8 (en) | Tricyclic sulfonamide compounds and methods of making and using same | |
| IN2012DN02177A (enExample) | ||
| IN2012DN02730A (enExample) | ||
| IN2012DN00754A (enExample) | ||
| GEP20094844B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
| MX2020012426A (es) | Anticuerpos anti-cd38. | |
| IL183160A0 (en) | Indazole-carboxamide compounds | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| EP3219725A3 (en) | Dkk1 antibodies and methods of use | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| MX2009008787A (es) | Moduladores 2-aminopirimidina del receptor de histamina h4. | |
| DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
| IN2012DN02471A (enExample) | ||
| WO2006058868A3 (de) | Substituierte pteridine zur behandlung von entzündlichen erkrankungen | |
| MX347734B (es) | Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas. | |
| GEP20094843B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
| WO2011116212A3 (en) | Bone morphogenetic protein receptor binding agents and methods of their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |